Healthcare Integrated Technologies Inc
For the period ended Jan 31, 2024. Filed Mar 18, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2024 · Filed Mar 18, 2024
SSGCStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Consolidated Statements of Cash Flows (Unaudited)
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the Six months Ended January 31, | |||
|---|---|---|---|
| 2024 · 2023 | |||
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net loss | $(383,663) | $(860,991) | |
| Adjustments to reconcile loss to net cash used in operating activities: | |||
| Amortization | 111,394 | 11,865 | |
| Stock-based compensation | 25,835 | 163,911 | |
| Cash received from deferred revenue | 105,189 | - | |
| Amortization of debt discount | - | 194,395 | |
| Change in fair value of derivative liability | - | 139,631 | |
| Changes in operating assets and liabilities: | |||
| Accounts receivable, net | (56,000) | - | |
| Prepaid expenses and other current assets | 1,070 | 1,277 | |
| Accounts payable and accrued expenses | 191,058 | 40,769 | |
| Accounts payable and accrued expenses, related party | 69,966 | 161,700 | |
| Payroll related liabilities | 122,722 | 86,552 | |
| NET CASH PROVIDED (USED) BY OPERATING ACTIVITIES | 187,571 | (60,891) | |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Cash paid for intangible assets | - | (5,610) | |
| NET CASH USED BY INVESTING ACTIVITIES | - | (5,610) | |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Proceeds from issuance of common stock | 100,000 | - | |
| Proceeds from related party loans | 37,797 | 65,466 | |
| Payments of amounts owed to related parties | (10,000) | - | |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | 127,797 | 65,466 | |
| Net change in cash and cash equivalents | 315,368 | (1,035) | |
| Cash and cash equivalents, beginning of period | 411 | 1,051 | |
| Cash and cash equivalents, end of period | $315,779 | $16 | |
| SUPPLEMENTAL CASH FLOW INFORMATION | |||
| Cash paid for interest | $ | - | $20,000 |
| SIGNIFICANT NON-CASH INVESTING AND FINANCING ACTIVITIES | |||
| Capital expenditures included in payroll related liabilities | - | $55,333 | |
| Capital expenditures included in accounts payable and accrued expenses | - | $4,294 | |
| Capital expenditures from stock-based compensation | - | $39,316 | |
| Issuance of common stock for payment of debt | - | $50,000 | |
| Issuance of common stock for payment of accrued expenses | - | $10,363 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.